Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven by increase in prevalence of heart diseases coupled with rising geriatric population and lifestyle related diseases. In order to cater to this increasing population suffering from cardiovascular diseases, drugs for treatment and prevention for these diseases is required. Rising number of diabetic patients is also expected to be another factor for growth of the global cardiovascular drugs market. According American Diabetes Association, in 2015, 30.3 Americans had diabetes, which is 9.4% of the total U.S population.
Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1167 Manufacturers in the market are focusing on mergers and acquisition and new product launches, which is positively affecting the market growth. However, stringent drug approval process and side effects of some cardiovascular drugs hamper growth of the global cardiovascular drugs market. Moreover, the patent expiry of various blockbuster drugs is also expected to adversely affect revenue growth of the global cardiovascular drugs market. According to American Heart Association (AHA), in 2013, cardiovascular diseases accounted for over 17.3 million deaths globally, representing 31% of all global deaths. The global number is expected to rise to 23.6 million by 2030. In 2010, the global burden of cardiovascular diseases was US$ 863 billion, and it is expected to rise to US$1044 billion by 2030. Around 2,200 U.S. citizens die due to cardiovascular diseases, everyday, which is one death in every 40 seconds. Moreover, coronary heart disease accounts for (45.1%) of the total cardiovascular disease, followed by stroke (16.5%), high blood pressure (9.1%), heart failure (8.5%), diseases related to arteries (3.2%), and other cardiovascular diseases in the U.S. Cardiovascular Drugs Market - Competitor Analysis Some of the major players operating in the global cardiovascular drugs market are Pfizer Inc., Bayer AG., Novartis AG., Merck and Co. Inc., AstraZeneca Plc, Bristol Myers Squibb Company, Abbott Laboratories, Sun Pharma Industries, Gilead Sciences Inc., Otsuka Holdings Co., Ltd. Takeda Pharmaceutical Company Ltd, Eli Lilly and Company, and Johnson & Johnson. Global Cardiovascular Drugs Market Taxonomy On the basis of drug class, the global cardiovascular drugs market is segmented into:
On the basis of distribution channels, the global cardiovascular drugs market is segmented into:
To know the latest trends and insights prevalent in the cardiovascular drugs market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/cardiovascular-drugs-market-1167 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
0 Comments
Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. In the recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving wide range of opportunities and challenges. In case of opportunity, automated method of collection enables technologists to perform a greater variety of tests on smaller sample quantities with greater accuracy of outcomes than the manual blood collection process. Therefore, there is an increasing number of laboratories taking their pace in the market from their hematology and chemistry analyzers to automated platforms.
Request a Sample Copy of Blood Collection Devices Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1160 Increasing prevalence of certain disease conditions such as cancer, HIV/AIDS, diabetes, coronary heart disease, and anemia are the driving factor for the growth of the blood collection devices market. In addition, increasing numbers of surgeries and high demand for blood transfusion and casualty cases are further driving the growth of blood collection devices market. According to the Centers for Disease Control and Prevention (CDC), the U.S. reported 26,203 cases of Lyme disease for the period between 2006 and 2016. According to the same source, around 10,265 deaths were reported due to alcohol-impaired crashes in 2015 which accounted for around 29% of all traffic-related deaths in the U.S. Continuous product advancement in blood collection devices fuel the growth of the market Tasso, Inc., a company engaged in the manufacture of HemoLink, a simplified blood collection device used in the various diagnostic application received the US$ 3 million funding from Defenses Advanced Research Projects Agency (DARPA) to advances their HemoLink technology by collaborating with GenTegra LLC, a company engaged in the manufacture of product used in the biopreservation, biobanking and in vitro diagnostics. Moreover the continuous product development and future advances in the blood collection techniques are expected to propel the growth of blood collection devices market. Key players in the blood collection devices market: Some of the key players in the blood collection devices market includes Becton, Dickinson and Company, NIPRO Medical Corporation, Terumo Medical Corporation, Medtronic plc, Qiagen, Bio-Rad Laboratories, Inc., Haemonetics Corporation, and Fresenius SE & Co. KGaA. Blood Collection Devices Market Taxonomy: On the basis of type, blood collection devices market segmented into:
- Plasma collection tubes - Heparin tubes - Other tubes (EDTA, ESR and Microcapillary tubes
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/blood-collection-devices-market-1160 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] 5/29/2019 Orthopedic Prosthetic Devices Market Report Explored in Latest Research till 2026Read NowOrthopedic prosthetic devices are defined as external medical devices that substitute a missing skeletal part. Orthopedic prosthetics are a vital components for rehabilitation of injured or harmed skeletal system, associated musculature and joints. These devices are mainly used after trauma or surgical removal of body appendage, disability arising from congenital condition, or disabling illnesses.
Rising prevalence of lower limb amputation among diabetic patients is expected to boost growth of the orthopedic prosthetic devices market A major driver for market growth is the rising prevalence of lower limb amputations among diabetic patients such as diabetic foot problems, which is caused by changes in the blood vessels and nerves that leads to ulceration and subsequently leads to limb amputation. According to World Health Organization (WHO), as of 2017, 170 million people are estimated to be suffering from diabetes globally. Additionally, increasing number of trauma cases across the globe, is in turn, increasing the demand for orthopedic prosthetic devices and products. According to World Health Organization (WHO), 2017, around 50 million people are severely injured in road accidents every year across the globe. However, high costs of orthopedic products are expected to hinder the market growth. For Better Understanding – You Can Request Sample Copy of Report Before Buying Here: https://www.coherentmarketinsights.com/insight/request-sample/1150 North America is expected to be the growth engine of the market The global orthopedic prosthetic devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global orthopedic prosthetic devices market, owing to rising number of lower limb amputations among diabetic patients as well as affordability of these devices provided with customization and innovation. For instance, in September 2017, Zimmer, introduced an innovative persona partial knee system that is known to alleviate pain, restore mobility, and improve the quality of life of the patients. Asia Pacific is expected to witness significant traction in the global orthopedic prosthetics devices market, owing to the changing healthcare scenario and development of new policies and regulatory fronts in countries in the region. For instance, the formulation of Indian Certification of Medical Devices (ICMD) by the Indian Healthcare regulatory body is expected to bring credibility to the devices manufactured by regional companies, in turn driving growth of the orthopedic prosthetic devices market. Novel innovations in prosthetic devices adopted by key players to establish significant position in the global orthopedic prosthetic devices market Key players operating in the global orthopedic prosthetic devices market include Smith & Nephew, Stryker Corp., DePuy Synthes, Zimmer Biomet, Medtronic Spinal, DJO Global, Integra Lifesciences, NuVasive Inc., Globus Medical, and Wright Medical. The key players are focusing on strategic mergers and acquisitions and development of innovative systems. For instance, in October, 2017, Zimmer Biomet Holdings Inc., introduced Avenue T TLIF Cage (Avenue T) in the U.S. Avenue T manufactures advancements in the posterior lumbar cage technology, through incorporation of VerteBRIDGE plating. The plating facilitates intra-discal fixation and cage insertion through minimally invasive procedure. Avenue T joins the previously introduced family of its product line of cages, including Avenue L Lateral Lumbar Cage, ROI-C Cervical Cage, and ROI-A ALIF Cage with VerteBRIDGE plating. Avenue T is the first product with posteriorly implanted cage, integrated with anti-migration fixation. Market Taxonomy On the basis of device type, the global orthopedic prosthetic devices market is segmented into
On the basis of technology, the global orthopedic prosthetic devices market is segmented into
To know the latest trends and insights prevalent in the orthopedic prosthetic devices market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/orthopedic-prosthetic-devices-market-1150 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Heat and cold therapy is a non-invasive and non-addictive pain relief therapy used for muscle relaxation, improving blood circulation, and reducing swelling. Heat and cold therapy is the most effective, inexpensive, and rapid relief treatment therapy. Different types of injuries cause swelling and inflammation, for which application of ice decreases the blood flow towards injury thereby, reducing the swelling and inflammation. However, heat therapy aids in increasing blood flow in turn supplying nutrients and oxygen in order to relax the ligaments and muscle. Heat is applied by electric or microwave heating pads, hot water bath or gel packs. Whereas, cold therapy is consists of ice or cold gel packs. Heat and cold therapy are good for strains, sprains, and bruises that occur during heavy physical or sports training sessions.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1133 Increasing adoption of non-surgical and non-pharmaceutical pain relive management therapies is expected to boost growth of the hot and cold therapy packs market According to World Health Organization (WHO) 2015, approximately 8 million individuals face minor accidents, every day. Thus, minimal injuries due to accidents and its treatments to relieve the pain are factors expected to fuel the hot and cold therapy packs market growth. Moreover, according to the Arthritis Foundation, cold packs are best for severe pain in body parts whereas, heat treatment such as warm baths and heating pads are likely to aid in relaxing stiff joints and muscles. Enhanced access to healthcare services such as easy availability of pain and injury relief therapies and increased personal health care spending are factors anticipated to boost the hot and cold therapy packs market growth. Moreover, market is witnessing growth due to increasing inclination of the populace towards non-surgical pain solutions and wound management for pain relief. For instance, according to a study conducted by University of Leiden in 2015, majority of surgeons recommended non-surgical treatments such as physical therapy or acetaminophen therapy for the treatment of osteoarthritis. Moreover, geriatric population suffering from chronic illness such as osteoporosis and arthritis prefer home care such as hot and cold therapy packs instead of frequently visiting hospitals or consuming drugs. The use of hot and cold therapy packs is safer and easy as compared to drugs and physiotherapy treatment. Thus, increasing non-pharmacological cure treatment for pain relive especially in geriatric population is a driving factor for growth of the market. However, increasing adoption of herbal and reusable packs for pain relief are factors expected to hinder the market growth. Top Key Players Major key players in the global hot and cold therapy packs markets include 3M, Caldera International Inc., Cardinal Health, Chattanooga Group Inc., Halyard Health, Inc., Beiersdorf Australia Ltd., Breg, Inc., Corso Enterprises, Inc., Covidien plc., Core Products International, Inc., DJO Global, Inc., Kobayashi Pharmaceutical Co., Ltd., Medline Industries, Inc., Bruder Healthcare Company, Inc., Thermionics Corp., and Carex Health Brands. Market Taxonomy The global hot and cold therapy packs market is segmented on the basis of product type, application type, distribution channel, and geography. On the basis of application type, the global hot and cold therapy packs market is segmented into:
On the basis of product type, the global hot and cold therapy packs market is segmented into:
For More Information, Browse Full Report Here: https://www.coherentmarketinsights.com/ongoing-insight/hot-and-cold-therapy-packs-market-1133 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types of cancer conditions. Recognition of sign and symptoms of disease are done through biopsy, a process of taking sample from region of interest such as skin, tissue or tumor for further diagnosis. Biopsy are primarily done to look for cancer detection or to detect rejection of transplanted organ draft.
Biopsy is done to identify likely cause of cancerous and non-cancerous tissue, which are unable to detect through CT-scan or X-rays. Depending on area of sample collection various biopsy procedures are done such as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy, liver biopsy, and prostate biopsy. Furthermore biopsy can be done using needle biopsy, CT guided biopsy, Ultrasound biopsy, and surgical biopsy for the tissue diagnostic. According to the American journal of Nephrology, 2015, Australia has the highest numbers of annual renal biopsy rates (215 persons/million person/year) followed by the Finland (176 persons/million person/year) and U.S. (175 persons/million person/year). The increased numbers of biopsy procedure likely to fuel the growth of tissue diagnostic market, in near future. Get Exclusive Sample Copy of Tissue Diagnostic Research @ https://www.coherentmarketinsights.com/insight/request-sample/1112 Rising prevalence of different cancer incidences is major driving factor boosting the tissue diagnostic market. According to American cancer Society (ACS), 1.6 million new cases of cancer diagnosed in the U.S., in 2016. In addition, increase research funding in cancer treatment and growing healthcare expenditure likely to show gradual rise in tissue diagnostic market. National Cancer Institute, in 2015, spends US$ 4,480 million on various types of cancer research which includes breast cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, leukemia, ovarian cancer and uterine cancer. Rise in the prevalence of cancer incidences to boost the tissue diagnostic market According to the United States Cancer statistics report published in 2014 by Centers of Disease Control and Prevention (CDC), between 1999 and 2014, more than 1600 people a day, died due to the cause of cancer. Although screening tests helps to detect cancer condition at early stage, data from Healthy People 2020, an initiative form Department of Health and Human Services, reveals that screening rate is still below the national targets set. Combined data collected from CDC and National cancer institute (NCI) focus on the top 3 cancer incidences in male and female. In male prostate cancer incidence are higher, while in females breast cancer are most dominated, followed by lung and colon cancer respectively in both male and female. New and advanced methods of tissue diagnosis favors the market growth Innovation in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence in situ hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the opportunity to grow tissue diagnostic market in future. In September 2017, researchers at the University of Texas, developed a new way of diagnosis by creating pen named as “MasSpec Pen”, which is handheld devices able to distinguish healthy tissue and tumor tissue in just 10 seconds, more than 150 times quicker than existing technology. These new tool provides improvement in cancer treatment and minimizes the chances of recurrence by offering precise diagnostic information, which eventually favors the growth in tissue diagnostic market. Global Eminent Players Key players operated in the tissue diagnostic market are Biocare Medical, Agilent technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp., Biogenex Laboratories, Life Technologies and Abbott laboratories. Tissue diagnostic market taxonomy: By Technology:
By Disease:
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/tissue-diagnostic-market-1112 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] 5/29/2019 Gastroscopy Devices Market –Modest Situation Among the Top Manufacturers, With SalesRead NowGastroscopy is a type of endoscopy performed for diagnosis of diseases pertaining to esophagus, stomach, and upper part of small intestine. It is also called upper gastrointestinal endoscopy. It is one of the most important discoveries in the field of medical science. Esophagoscope was also a type of endoscopy that was used for diagnosis and treatment procedures of esophagus. Gastroscopy has replaced esophagoscopes completely. The only difference between esophagoscope and gastroscope is the length of gastroscope that is longer than esophagoscopes. Gastroscopy can also be performed to detect cancers. This procedure is recommended to diagnose problems related to the esophagus or stomach. The device has a light and a camera at the end of the probe that is used to see the esophagus, upper intestine and stomach clearly. It is also used to investigate problems related to swallowing, ulcers, and blockage in esophagus. This procedure allows practitioners to study the mucous membrane of the stomach. Gastroscopy are broadly classified into two types namely diagnostic gastroscopy used to diagnose or confirm diagnosis and treatment gastroscopy for therapeutic purposes. Esophagus cancer is the eighth-most common cancer in the world. As per the report of World Cancer Research Fund International, there were around 456,000 new esophagus cancer cases diagnosed in 2012. Gastroscopy is considered as the most preferred option for screening of esophagus cancer and polyps by most gastroenterologists and thus, the gastrointestinal endoscopy devices market is projected to witness significant traction in the foreseeable future.
High Incidence of Esophageal Cancer Fueling Gastroscopy Devices Market Growth Esophageal cancer is of two types namely, adenocarcinoma and squamous cell carcinoma. Esophageal cancer can occur due to various reasons such as gene type that includes gene mutations or damage involved in cell divisions. As per results of an independent study, overweight and obesity increases the risk of esophageal cancer by 48% per 5 BMI units. Polyp detection rate of esophagus and stomach depend upon the proportion of mucosal surface diagnosed and correlates to time dedicated for diagnosis. Gastroscopes consist of a flexible tube with a high definition camera at the end of the probe. The quality of camera defines the quality of diagnosis. The long length of device is used to examine the complete length of the esophagus. Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/132 Gastroscopy Devices Market: Drivers and Restraints The global gastrointestinal endoscopy devices market is expected to be fueled by advancements in endoscopy technology. Key drivers of the market are increasing cases of esophageal cancer and polyps, growing ageing population, family history of cancer, and changing lifestyle. Increasing government initiatives to diagnose and treat early stage cancers are also expected to fuel gastrointestinal endoscopy devices market. For instance, in 2014, The European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) created a community of endoscopy services across Europe, collaborating with each other to provide high quality, safe, accurate, patient-centred and accessible endoscopic care. The lack of awareness, dearth of experienced professionals, lack of reimbursement policies, and increasing cases associated with bio-dirt is expected to hinder growth of the market. Gastroscopy Devices Market: Overview Technological advancements in gastroscopy technique are expected to drive growth of the market for gastroscopy device, as these significantly improve detection rate as compared to other conventional procedures. Practitioners prefer using flexible gastroscope over non-flexible gastroscopes due to high quality, less breakage problems and high illumination for better imaging provided by the former. Increasing awareness among practitioners of using the advanced gastroscopy over white light traditional gastroscopy is showing a significant growth towards flexible video gastroscopy. Increasing cases of biodirt provides opportunity to gastroscopy manufacturers to introduce products with innovative features to avoid such cases of infections. Hospital end user segment is expected to remain dominant in the market over the foreseeable future. Key players operating the gastroscopy devices market include Olympus, Karl Storz, Sono Scape, Endomed, Medigus, Fujifilm Holdings Corporation and Huger. Click To Reading More On Gastroscopy Devices Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] 5/29/2019 Hyperspectral Imaging Market 2019 with Top 20 Countries data :Growth Factors, Key CompaniesRead NowHyperspectral imaging (imaging spectroscopy) systems are the result of extensive research and activity efforts. These systems have various applications in sectors such as healthcare, research and development, food industry, defense sector and others such as remote sensing, calorimetry and night vision. Hyperspectral imaging differs from multispectral imaging based on quality of image and provides greater sensitivity than conventional or multispectral imaging. For instance, multispectral imaging provides 2 to 20 images per dataset, while hyperspectral imaging provides over 20 images per dataset. Also, multispectral imaging gives 4 to 20 data points per pixel, while hyperspectral imaging provides full spectrum per pixel.
Increasing deployment of hyperspectral imaging in healthcare sector creates a highly conducive environment for growth of the hyperspectral imaging market in the near future. Hyperspectral imaging finds wide application in medical imaging, ophthalmology, and is also used in the procedures of gastrointestinal tract, in vascular systems and in tissue diagnosis. It is also an integral part of wound analysis, cell biology, and fluorescence microscopy. Wide application of the technology is mainly attributed to its high accuracy and clarity. Request A Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/240 Increasing adoption in pharmaceuticals sector fueling growth of the hyperspectral imaging market, especially in emerging economies The global hyperspectral imaging systems market globe is expected to witness double digit growth in the near future. In healthcare sector, these systems are used to perform various procedures in the pharmaceuticals industry. These include systems used to perform quality control tests that help detect foreign material present in drugs, and also mixed chemicals in counterfeit drugs. Also, hyperspectral imaging systems help in identification of targeted tumor tissue, a blood vessel, lymph nodes, a nerve bundle by covering the surface area of target and providing the image, in which that pixels of the image contains information regarding various light wavelength bands. Also, hyperspectral imaging finds extensive application in cancer treatment, as these systems provide real-time data and help in understanding the changes of tissue, which occur in the early stages of development of disease, also it helps to differentiate healthy cells from cancerous cells. North America holds the largest share in the global hyperspectral imaging systems market, followed by Europe. This is mainly attributed to high healthcare spending, robust healthcare infrastructure, and inclination towards adoption of novel technologies. Also, the market in APAC region is projected to witness high growth rate over the next few years, due to increasing economic growth and developing healthcare sector. Growth factors and restraints of the hyperspectral imaging market The innovative products with advanced technology, high patient and operator safety, superior accuracy and consistency are the leading factors driving growth of the hyperspectral imaging market. The major challenge in this market is high cost of this systems, lack of awareness about the applications of these systems, dearth of skilled operators, high investment costs and implementation of healthcare regulatory policies that delay approval for this systems in some regions. Some are the key companies providing innovative products in this area are Headwall Photonics, HyperMed Imaging, Inc, Spectral Imaging Ltd., imec, Norsk Elektro Optikk AS (NEO), SpekLED GmbH and Resonon. Click To Reading More On Hyperspectral Imaging Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] Hypodermic needles are hollow needles that are attached with hypodermic syringes for injecting saline solution or solution containing liquid medicines and drugs. These needles are also useful in extraction of fluids such as blood from the body. Hypodermic needles can be used as disposable as well as reusable needles. The reusable needles must be sterilized before use due to their ability to cause various diseases or infections that might transmit if they are not sterile. Disposable hypodermic needles aids an important role in research environments where sterile conditions are required and it also reduces contamination significantly during inoculation of a sterile substrate. Thus, preventing colonization of airborne pathogens on the needles surface. Hypodermic needles are primarily of two types, which include safety and non-safety hypodermic needles. Safety hypodermic needles are the needles on the safety syringe that can be permanently attached or detachable thus preventing healthcare professional from needle stick injuries. Whereas, non-safety hypodermic needles are the conventional syringe needles, which lack safety mechanisms thereby possessing higher chances of needle stick injuries.
Get In-Depth Sample Copy of Hypodermic Needles Market Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1102 Rising demand for vaccines is expected to boost the hypodermic needles market The factors that are contributing to the growth of hypodermic needles market are rising demand for intravenous vaccines delivery mode. There are numerous vaccines that are recommended for injection into muscle (intramuscularly) although some are delivered through subcutaneously and intradermally. Furthermore, increasing prevalence of chronic diseases and rising compliance for safety needles so as to curtail the incidences of needle stick injuries are the other factors that are contributing to the growth of hypodermic needles. However, rising incidence of needle stick injuries and risk of infections associated with administering drugs using hypodermic needles are hindering the growth of hypodermic needles market. The innovative K pack Surshield launched by Terumo Medical Corporation is expected to propel the market growth The key players in the hypodermic needles market include Albert David, Becton, Connecticut Hypodermics, Retractable Technologies, Novo Nordisk, BD, Covidien, Terumo Medical Corporation, Dickinson, Vygon, Vita Needle Company, Unilife Corporation, Hindustan Syringes & Medical Devices Limited, and Nipro Medical Corporation. The key players are focusing on strategic mergers and acquisition and development of innovative systems. For instance, Terumo Medical Corporation has launched an innovative hypodermic needle known as K-Pack Surshield in 2012, which has an integrated passive sharps protection feature with pre filled syringes. The device is used to allow automated manipulations during the packaging process, which makes it ideal for inclusion and bundling into the secondary packaging of parenteral medication. Hypodermic Needles Market Taxonomy: Hypodermic Needles Market is segmented on the basis of Product type, end user, and geography On the basis of product type, hypodermic needles market is segmented into:
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/hypodermic-needles-market-1102 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Gas chromatography is a technique used for analyzing and separating compounds that can vaporize without decomposing. It is used to test purity and quality of substances, analyze biological specimen, and forensics. Moreover, gas chromatography and mass spectrometry (GC-MC) is also used to detect drugs, identify and investigate unknown and explosive samples. Gas chromatography a wide range of application in various field such as chemicals, healthcare, oil and gas, agriculture, academics and research institutes, forensic, environmental, and clinical toxicology. In biotechnology and pharmaceutical domain, gas chromatography is used for analytical research and development, drug formulations and production, quality control, and quality assurance. Furthermore, it is used in detection of nucleic acid, proteins, fats, carbohydrates, vitamins and metabolic profiling. Advancements in technology in gas chromatography products such as GC-2010 plus and GC-2014, which are temperature-programmed chip-based GC helps to decrease analysis time, enhance performance, and provide accuracy.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1092 Global Gas chromatography Market – Trends and Opportunity Researchers are more focused on innovation in gas chromatography, in order to improve robustness, selectivity, and sensitivity. For instance, in May 2017, Electronic Sensor Technology Inc., developed and received patent for its breakthrough chemical vapor analysis process. This process is applied on gas chromatography calculations. This technology several advantages in life science, chemical and petrochemical, environmental, and food and beverages sectors. This is owing to the accuracy and real-time analysis of chemical odors and vapors, which helps in investigation of bacteria. Moreover, in February 2017, Ellutia Chromatography Solutions Co. launched 500 series of Ultra-Fast Gas Chromatography (UFGC) with features such as air blown oven and directly heated columns. These help in increasing ramp rates, upper temperatures limits and decreases cool down times reducing energy consumption. Such features help in reducing cycle time by up to 10 times. Therefore, it is a less time consuming process, which is favorable for growth of the gas chromatography market. In September 2017, PerkinElmer, Inc. launched Clarus 590 and 690 gas chromatography instruments. It has features such as comprehensive portfolio of sampling accessories, TurboMatrix headspace and thermal desorption options, along with the new TurboMatrix MultipPrep technology. It offers more flexibility and higher throughput and optimized injection, which helps to detect harmful contaminants in food, environment, petrochemical, and pharmaceutical samples. Thus, advancement in technology and beneficial features of these instruments caters to various industry demands, which directly favors growth of the gas chromatography. Increasing GC adoption by various industries is expected to favor growth of the gas chromatography market Increasing adoption of gas chromatography by various industries is major factor fueling growth of gas chromatography market. Moreover, increasing private and government investments in research and development for drug formulation and development is another key factor that will support the growth of gas chromatography market. Rising awareness about therapeutic-based application will boost growth of the gas chromatography market in the near future. Key Players Major players in the gas chromatography market are Thermo Fisher Scientific, Inc., CMC Instruments, Agilent Technologies, LECO Corporation, GmbH Rudolf Dieselstrasse and Shimadzu Corporation. Global Gas chromatography Market taxonomy – By Instrument –
By Accessories and Consumables –
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/gas-chromatography-market-1092 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Colostomy is a surgical procedure in which an opening is formed by drawing the healthy end of the large intestine or colon by an incision in the anterior abdominal wall and then suturing and setting it into place. This helps the patient in better bowel motions through the stoma and collected in special disposable colostomy bag, which fits over the stoma and sticks to the skin. Colostomy can be permanent or temporary, as colostomy can be reversed by joining two ends together. Colostomy bags market is gaining traction due to increasing prevalence of diseases such as irritable bowel syndrome, multiple sclerosis, Crohn’s disease and cancer. Besides these colostomy can be performed due to birth defects or accidental injury. The broad spectrum regarding the causes for the disease is expected to favor the growth in colostomy bags market in the near future.
Colostomy bags market is backed by some of the factors as they does not bring significant changes in lifestyle as most of the people are allowed to follow the diet as earlier and perform their daily routine after the surgery. Furthermore, to avoid infections around colostomy bag due to spillage of stool, sweating, dislocation of colostomy bags wide range of accessories are provided, which includes support belts, girdles, deodorizers, skin protective wipes and stoma paste. Moreover, there are different types of colostomy bags such as closed bags, drainable bags, one piece system and two-piece system that are designed according to patients need. Request A Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/503 Rise in incidence of Crohn’s disease and bowel cancer is expected to fuel the growth of colostomy bags market in the near future Crohn’s disease is a type of inflammatory bowel disease (IBD) which can affect any part of gastrointestinal tract from mouth to anus which increase the market of colostomy bags. According to Centers for Disease Control and Prevention (CDC), 1.0-1.3 million people suffer from inflammatory bowel disease (IBD) as Crohn’s disease is more common in smokers. Whereas each year in the U.S. around 54,000 men and 17,000 women get bladder cancer according to Centers for Disease Control and Prevention (CDC), which significantly supports the rise in growth percentage of colostomy bags industry. The statistics provided above are expected to be a set of crucial factors that supports the growth in colostomy bags market over the forecast period. Regional growth engines of the colostomy bags market On the basis of regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The global market is projected to show growth expansion in Asia Pacific due to the rise in incidence of colorectal cancer, increase in aging population and increase in medical tourism. According to Centers for Disease Control and Prevention (CDC) report in 2014, the highest incidence of colorectal cancer was reported in Asia Pacific and Hispanic with approximately 35 people out of 100,000 in 2013. The key players dominating the global colostomy bags market Providers in the market offer a broad range of colostomy bags and accessories and in increase in adoption of market strategies such as online marketing due to advanced technology to manufactures innovation in product competition in market is increasing. The key players operating the market of colostomy bag includes, Coloplast, ConvaTec, TG Eakin Hollister, Marlen, B. Braun Oakmed, and Welland Medical. Click To Reading More On Colostomy Bags Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] |
Details
Global Industry Research Experienced Professional Freelancer with a demonstrated history of working in the information technology and services industry. Skilled in Front Office, Customer Service, Marketing, Microsoft Office, and Social Media. Strong media and communication professional with a Bachelor of Commerce - BCom focused in Computer and Information Sciences and Support Services from Pune University. Archives
July 2020
Categories |